We can improve the lives of the world's poorest people by incorporating low-cost, rapid-impact packages of drugs for neglected tropical diseases into ongoing programs for the control of HIV–AIDS, tuberculosis, and malaria.
No takes yet. Share an insight, caveat, or question.
Hotez et al. (2011) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: